This video is featured in the 2024 ASH Annual Meeting Insights Hub

ASH 2024 Insights: HRQoL With Luspatercept vs. Epoetin Alfa in RBC Transfusion-Dependent Lower-Risk MDS - COMMANDS Study

26 views
December 20, 2024
Comments 0
Login to view comments. Click here to Login